Original Research

Published on 22 Mar 2022

Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway

in Pharmacology of Anti-Cancer Drugs

Yamei Li
Hai Liu
Xiaoxuan Liu
Bang Xiao
Minhong Zhang
Yaoling Luo
Mingchun Li
Jianqiong Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.851300

3,112 views
9 citations

Review

Published on 22 Mar 2022

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples

in Pharmacology of Anti-Cancer Drugs

Nick Verougstraete
Veronique Stove
Alain G. Verstraete
Christophe P. Stove

Frontiers in Oncology

doi 10.3389/fonc.2022.821807

4,901 views
14 citations

Original Research

Published on 22 Mar 2022

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells

in Pharmacology of Anti-Cancer Drugs

Huayuan Liu
Lei Zhao
Mengya Wang
Kexin Yang
Zhipeng Jin
Chengjian Zhao
Guangjun Shi

Frontiers in Oncology

doi 10.3389/fonc.2022.852095

4,115 views
23 citations

Original Research

Published on 21 Mar 2022

Elaiophylin Inhibits Tumorigenesis of Human Uveal Melanoma by Suppressing Mitophagy and Inducing Oxidative Stress via Modulating SIRT1/FoxO3a Signaling

in Pharmacology of Anti-Cancer Drugs

Xue Zhu
Wenjun Zou
Xinmin Meng
Jiali Ji
Xun Wang
Hong Shu
Yuan Chen
Donghui Pan
Ke Wang
Fanfan Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.788496

3,614 views
10 citations

Original Research

Published on 18 Mar 2022

Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma

in Pharmacology of Anti-Cancer Drugs

Kejuan Li
Fengming You
Qin Zhang
Ruijiao Yuan
Qianghua Yuan
Xi Fu
Yifeng Ren
Qian Wang
Xiaohong Li
Zhenya Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.849579

3,204 views
2 citations

Original Research

Published on 17 Mar 2022

Sevoflurane Induces Ferroptosis of Glioma Cells Through Activating the ATF4-CHAC1 Pathway

in Pharmacology of Anti-Cancer Drugs

Yingyi Xu
Na Zhang
Cheng Chen
Xinke Xu
Ailing Luo
Yaping Yan
Yanhua Lu
Jianhua Liu
Xinxu Ou
Yonghong Tan

Frontiers in Oncology

doi 10.3389/fonc.2022.859621

7,229 views
31 citations

Review

Published on 17 Mar 2022

Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models

in Pharmacology of Anti-Cancer Drugs

Qingfan Zheng
Bin Zhang
Changfeng Li
Xuewen Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.850732

4,393 views
14 citations

Original Research

Published on 17 Mar 2022

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

in Pharmacology of Anti-Cancer Drugs

Victoria Heredia-Soto
Javier Escudero
María Miguel
Patricia Ruiz
Alejandro Gallego
Alberto Berjón
Alicia Hernández
Marta Martínez-Díez
Shuyu Zheng
Jing Tang

Frontiers in Oncology

doi 10.3389/fonc.2022.862321

2,778 views
2 citations

Original Research

Published on 17 Mar 2022

Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity

in Pharmacology of Anti-Cancer Drugs

Chia-Chi Liu
Yeon Jae Kim
Rachel Teh
Alvaro Garcia
Elisha J. Hamilton
Flemming Cornelius
Robert C. Baxter
Helge H. Rasmussen

Frontiers in Oncology

doi 10.3389/fonc.2022.859216

1,998 views
2 citations

Case Report

Published on 15 Mar 2022

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Xing He
Yaorong Peng
Zhenyu Zhou
Wenbin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.784224

2,565 views
3 citations

Original Research

Published on 15 Mar 2022

Exploration of the Potential Mechanism of Qi Yin San Liang San Decoction in the Treatment of EGFRI-Related Adverse Skin Reactions Using Network Pharmacology and In Vitro Experiments

in Pharmacology of Anti-Cancer Drugs

Yalei Wang
Yali Zhang
Chengcheng Ding
Caixia Jia
Huawei Zhang
Tiantian Peng
Shuo Cheng
Weihang Chen
Yan Tan
Xu Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.790713

4,401 views
6 citations

Review

Published on 14 Mar 2022

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer

in Pharmacology of Anti-Cancer Drugs

Jingwen Jiang
Jiayu Li
Xiumei Zhou
Xueqin Zhao
Biao Huang
Yuan Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.864980

4,584 views
34 citations

Original Research

Published on 14 Mar 2022

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study

in Pharmacology of Anti-Cancer Drugs

Hon-Yi Shi
Yen-Cheng Chen
Ching-Wen Huang
Ching-Chun Li
Wei-Chih Su
Tsung-Kun Chang
Po-Jung Chen
Tzu-Chieh Yin
Hsiang-Lin Tsai
Jaw-Yuan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.756078

2,262 views
1 citation

Case Report

Published on 14 Mar 2022

Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature Review

in Pharmacology of Anti-Cancer Drugs

Qin-qin Liu
Hao-ming Lin
Hong-wei Han
Cai-ni Yang
Chao Liu
Rui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.803454

2,113 views
5 citations

Original Research

Published on 11 Mar 2022

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Jia Zheng
Zhihong Yang
Yanlei Li
Li Yang
Ruili Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.823491

5,443 views
10 citations

Case Report

Published on 10 Mar 2022

Case Report: Niraparib-Related Pulmonary Embolism During the Treatment of BRCA Mutant Advanced Ovarian Cancer

in Pharmacology of Anti-Cancer Drugs

Qiang Wei
Dong-Sheng Chen
Yuan-Hua Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.853211

2,095 views
5 citations

Navigation group

Articles

Gracillin Shows Potential Efficacy Against Non-Small Cell Lung Cancer Through Inhibiting the mTOR Pathway

Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples

FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells

Elaiophylin Inhibits Tumorigenesis of Human Uveal Melanoma by Suppressing Mitophagy and Inducing Oxidative Stress via Modulating SIRT1/FoxO3a Signaling

Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma

Sevoflurane Induces Ferroptosis of Glioma Cells Through Activating the ATF4-CHAC1 Pathway

Overcome Drug Resistance in Cholangiocarcinoma: New Insight Into Mechanisms and Refining the Preclinical Experiment Models

Antitumoral Effect of Plocabulin in High Grade Serous Ovarian Carcinoma Cell Line Models

Displacement of Native FXYD Protein From Na+/K+-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity

Immune Checkpoint Inhibitor-Based Systemic Therapy Shows Remarkable Curative Effect in a Hepatocellular Carcinoma Patient With Intractable Postoperative Recurrence and Metastases: A Case Report and Literature Review

Exploration of the Potential Mechanism of Qi Yin San Liang San Decoction in the Treatment of EGFRI-Related Adverse Skin Reactions Using Network Pharmacology and In Vitro Experiments

Exosomes Regulate the Epithelial–Mesenchymal Transition in Cancer

Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study

Complete Response to Combined Chemotherapy and Anti-PD-1 Therapy for Recurrent Gallbladder Carcinosarcoma: A Case Report and Literature Review

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma

Case Report: Niraparib-Related Pulmonary Embolism During the Treatment of BRCA Mutant Advanced Ovarian Cancer